neck, may I add that (when) 04' stored IBC/CorCell HSCT sample was removed from CorCell inventory (07 - 2011 and ongoing) for a known transplant how do shareholders get paid? Is IBC floating the fees? idk. The sample was never a client annuity product based on the original IBC/CorCell Sibling Donor contract. Right? So who is paying knowing the statistics and the new policy updates impacts the CBAI bottom-line immensely going forward in 2011.